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Abstract
Chronic cerebral ischemia (CCI), as a manifestation of age-related pathology shows strong parameters of the morbidity rate 
among the elderly. Cognitive impairments are one of main expressions of this pathology. The aim of this study was to evaluate the 
neurophysiological parameters of the cognitive impairments in patients with various stages of discirculatory encephalopathy (DE) in 
the comparative aspect. The cognitive functions were studied in 60 patients (main group) possessing various degrees of CCI (stages 
I-III DE) on a comparative basis. Among them, 20 patients had stage I DE (Group 1), 22 patients had stage II DE (Grope 2), and 18 
patients had stage III DE (Group 3). The control group included 15 volunteers of comparable age without any manifestations of CCI. 
The mean age was 62.4±12.4 years. The etiological factors of DE in our observations were arterial hypertension and atherosclerosis of 
the cerebral vessels, without occlusion of the major artery of head. Based on the neuropsychological tests in 49 patients (81.6%) of the 
main group, we found cognitive impairments in various degrees of severity. Normal age-related memory loss was observed in 14.9% 
while mild cognitive impairment (MCI) was seen in 66.7% of the cases. Among the types of MCI, the disregulatory type was observed 
in 51.6% of patients with stage II-III DE, and the combined type was observed in 45.4% of patients with stage III DE. The EEG-pattern 
in patients with DE has some peculiarities that are expressed in the predominance of rhythmical slow wave activity and the reduction in 
the coherence of alpha rhythmic activity that results in a consequent disturbance of the integrated brain activity. Changes in cognitive 
evoked potentials (CEP P300) were expressed in the shortening of P300 peak latency and an increase in P300 peak amplitude and 
consequently, a reduction the latency/amplitude ratio in patients having MCI associated with DE.
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Introduction
Chronic cerebral ischemia (CCI), as a manifestation of 
age-related pathology shows strong parameters of the morbidity 
rate among the elderly. Cognitive impairments are one of main 
expressions of this pathology. As this is a reflection of the state 
of the community as a whole, from this perspective, this problem 
acquires a medico-social character. Cognitive impairments occur 
in a wide spectrum ranging from normal ageing to dementia. 
Scientists, today, evince great interest, neurologists in particular, 
in detecting the early appearances of cognitive impairments, and 
specifically, mild cognitive impairment (MCI) which represents 
a stage of cognitive impairments, prior to reaching the stage of 
dementia; however, they exceed the limits of the age norm. The 
construct of mild cognitive impairment (MCI) has been proposed 
to designate an early, but abnormal, state of cognitive impairment 
[1]. As noted above, MCI occurs more often in patients with CCI 
and discirculatory encephalopathy (DE), stages I, II, and III [2-6].
The onset of memory loss complaints in elderly patients is 
a very important feature in the diagnosis of MCI. Investigations 
conducted in Russia revealed that only 17% of patients studied 
using the MMSE test (Mini-Mental Study Examination) had 
cognitive impairments within the age-related norms, 52% 
of patients had MCI and 30% showed dementia [3,7-9].  This 
enabled us to confirm that the frequency of MCI in the structure 
of the cognitive impairments in the elderly accounts for more than 
one-half of all the cases. Most cases revealed the transformation 
of MCI into dementia in a continuously increasing number of 
patients with MCI. According to some authors, this was indicative 
of the importance of studying this problem [3,5,8,10-13].
According to the data of the Canadian Study of Health and 
Aging, the rate of the incidence of MCI accounted for 11-17% 
among the old and senile. The date of this investigation showed 
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that the risk of development of MCI occurred at 65 years of age 
and older; during one year it was 5%, whereas during four years 
of follow-up it rose to 19% [14]. The frequency rate of MCI 
associated with CCI accounts for about 10% in patients between 
70 and 90 years, in 50% of patients with internal carotid artery 
occlusion, and in 70% of patients having previously suffered a 
stroke [13,14].
The progressive amnestic disorders appear to be the most 
frequent expressions of MCI. As a rule, they can combine with 
changes in the other cognitive spheres or remain isolated. Based 
on the neuropsychological profiles that R. Petersen [1] described 
four main types of MCI can be distinguished, which may be the 
predictors of some specific neurodegenerative diseases:  
1. Amnestic MCI Single Domain (a-MCI-single domain)- 
isolated memory impairment; a-MCI-single domain often 
progresses to Alzheimer’s disease.
2. Amnestic MCI  Multiple Domain (a-MCI-multiple 
domain) - two or more cognitive domains are impaired, one 
of which is memory impairment; a-MCI-multiple domain is a 
predictor of vascular dementia, disease of Lewy bodies. 
3. Non-Amnestic MCI Single Domain (na-MCI-single 
domain) - impairment in a single domain other than memory; na-
MCI-single domain is a predictor of frontal-temporal dementia. 
4. Non- Amnestic MCI Multiple Domain (na-MCI-multiple 
domain) - impairments in two or more domains but other than 
memory; na-MCI-multiple domain is a very rare subtype and a 
predictor of primary progressive aphasia.
The diagnosis of MCI, as a rule, is rather complicated, and 
it caused by several factors. For example, on neuropsychological 
testing, the parameters may be changed due to the effect of factors 
such as the education level of the patient, main disease duration 
and diagnostic sensitivity of this test during the identification of 
MCI. For example, some tests are insufficiently informative in 
the diagnosis of early forms of cognitive impairments. Cognitive 
evoked potential (CEP) is an important description of brain 
cognitive function. We selected CEP because it enables us to 
estimate the endogenous events occurring in the brain connected 
to the recognition and memorizing of the stimuli showed, in MCI 
patients.
The aim of this study was to evaluate the neurophysiological 
parameters of the cognitive impairments in patients with various 
stages of discirculatory encephalopathy in the comparative 
aspect. 
Material and Methods
The cognitive functions were studied in 60 patients (main 
group) possessing various degrees of CCI (stages I-III DE) on 
a comparative basis. Among them, 20 patients had stage I DE 
(Group 1), 22 patients had stage II DE (Grope 2), and 18 patients 
had stage III DE (Group 3). The control group included 15 
volunteers of comparable age without any manifestations of CCI. 
The mean age was 62.4±12.4 years. 
The etiological factors of DE in our observations were 
arterial hypertension and atherosclerosis of the cerebral vessels, 
without occlusion of the major artery of head. 
Distribution of the patients based on the degree of cognitive 
defect  was  done  in  line  with  the  classification  of  O.S.  Levin 
(2010), according to which there are different forms of MCI, as 
follows:
- amnestic type with the characteristic defect of episodic 
memory connected to the defect of memorizing (defect of 
perception, mediated memorizing and recognition) [4,14,15]; in 
the test for the free and directed verbal associations, a decrease in 
semantic speech activity was also possible; 
- disregulatory (frontal) type, characterized by the 
prevalence of frontal lobe dysfunction, which may be connected 
to the primary pathology of the frontal  cortex or is secondary 
in relation to the pathology of the deep structures (subcortical-
frontal syndrome); in this type, a secondary decline of memory 
with a defect in perception is noted, however, with preservation 
of recognition and memorizing; the decrease in speech activity 
(especially a reduction in the number of phonetic associations) is 
also typical;  
- the combined (multifunctional) type of MCI characterized 
by the association of the amnestic syndrome of the hippocampal 
type (with impairment of perception and recognition) with 
impairment of the regulatory or other cognitive functions; 
- MCI with prevailing impairment of any other cognitive 
sphere, for example, visual-spatial or speech (dysphasia) 
impairments.    
The  diagnosis  of  DE  was  verified  by  the  presence  of 
the background disease (in our observations this was arterial 
hypertension stage II, atherosclerosis of the cerebral vessels or 
their combination), marked by the occurrence of the complaints 
of a cerebral character in combination with slight or pronounced 
focal symptoms, as well as by the presence of cognitive 
impairments. Patients with severe cognitive impairments and 
dementia were excluded from the study.
All the patients had undergone clinical-neurological 
investigations and neuropsychological tests in order to verify the 
presence and stage of cognitive defect. The stage of cognitive 
defect was determined by the MMSE (Mini-Mental State Exam) 
test, the Clock Drawing Test (CDT), the Bourdon-Wiersma test 
(visual perception and vigilance), and the Spielberger-Hanin 
test. The neurophysiological investigations included an EEG 
study (21-cables) and cognitive evoked potentials (CEP P300) 
on the electroencephalograph Neuron Spectrum 4 (“Neurosoft”, 
Russia). Statistical analysis was performed using the statistical 
software «Statistica».
Results and Discussion       
Based on the neuropsychological tests in 49 patients 
(81.6%) of the main group, we found cognitive impairments in 
various degrees of severity (Table 1).  
Degree of  cognitive 
impairment
Stage of  DE
I II III Totally
Absence of cognitive 
impairment 11 (18.3%) - - 11 (18.3%)
Normal age-related 
memory loss 7 (11.66%) - 2 (3.3%) 9  (15%)
MCI 2 (3.33%) 22 (36.67%) 10 (16.7%) 34 (56.7%)
Advanced cognitive 
impairment - - 6 (10%) 6 (10%)
Total 20 (33.33%) 22 (36.67%) 18 (30%) 60 (100%)
Table 1. 
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From the data presented in Table 1, it is evident that the 
distribution of cognitive impairments in the patients at different 
stages of CCI reveals unique features. We rarely observed the 
normal age-related memory loss (3.3%) in the patients with stage 
III DE, whereas it was found in 11.6% of patients with stage I DE. 
On the contrary, in the patients with stage III DE, the cognitive 
defect in 63.4% of cases achieved a degree of MCI, while in the 
patients with stage I DE, MCI was registered only in 3.3% of 
the cases. It should be noted that in these cases the MCI was 
represented by the amnestic subtype, which according literature 
data was frequently transformed into the Alcgeimer’s disease. 
Therefore, it is possible to say, that in this case, most likely, the 
cognitive impairment is combined with a neurodegenerative 
process. The greatest number of MCI was observed in the patients 
with stage II DE. 
As noted above, MCI was observed in 66.7% of case. 
Distribution of the patients studied by the type of MCI based on 
O.S. Levin’s classification is presented in Fig. 1. 
From the data presented, it is evident that the disregulatory 
and combined types of MCI occurred more frequently. In other 
words, MCI may be considered as an indicator of morpho-
functional insufficiency of the brain associated with progressive 
CCI. Therefore, if at stage I DE, the normal age-related memory 
loss or its absence was noted more frequently, then during the 
progression of the main process, the disregulatory type (at stage 
II-III DE) or combined type (at stage III DE) of MCI was found 
more often. Based on these facts, we concluded that the stage of 
cognitive impairment reflected the stage of cerebral insufficiency. 
In this connection, the question arises regarding the development 
of more informative diagnostic criteria for MCI. 
Neuropsychological tests appeared to be widely used in 
the diagnosis of cognitive impairment. These tests are used to 
perform the early cognitive impairment diagnosis and determine 
its severity degree. The simplicity of this diagnostic method is 
also advantageous. As shown above, the degree of the cognitive 
defect was defined by the MMSE test, the CDT, and the Bourdon-
Wiersma test (visual perception and vigilance). Reactive anxiety 
and personal anxiety were measured using the Spielberger-Hanin 
test.  Data of neuropsychological tests are presented in Figure 2.
The data presented in Fig.2 showed that MMSE score was 
25.8±1.6 points in Group 1 patients that corresponded to MCI. In 
Group 2 patients, this score rose to 30 points. A detailed study of 
MMSE score revealed that in the patients with MCI functions such 
as memory and concentration of attention were damaged more 
frequently, which was typical for the combined and disregulatory 
types of MCI. The latter was confirmed by the Bourdon-Wiersma 
test too.  The Bourdon-Wiersma test score in Group 1 patients was 
4.3±0.4 points, while in the control group it was 5.6±0.6 points. 
An analysis of the reactive anxiety by the Spielberger-Hanin 
test confirmed the presence of this anxiety in patients with MCI 
associated with CCI. The index of reactive anxiety in Group 1 
patients was 47.6±8.4 points, whereas in the control group it was 
31.2±4.1 points, which was evaluated as the norm. It is important 
to note that the differences were reliable. Personal anxiety by the 
Spielberger-Hanin test in patients with MCI and in the control 
group was 41.5±6.4 points and 38.0±5.8 points, respectively, and 
the differences were not statistically significant. In addition, the 
differences by the CDT were not statistically significant (7.8 ±8.3 
and 9.4±0.6 points, respectively).
In this study, the neurophysiological characteristics of 
MCI were investigated. The peculiarities of the bioelectric 
brain activity and parameters of cognitive evoked potentials 
(CEP P300) were studied using the EEG. The main parameters 
studied were P300 peak latency and P300 peak amplitude.   
Neurophysiological investigations were performed in patients 
with normal age-related memory loss and with MCI. In such 
cases, the distribution of the main rhythms of the brain, their 
power and zonal distribution were taken into account. These data 
are shown in Table 2.
An analysis of the EEG parameters revealed their 
dependence on the stage of cognitive impairment. The EEG in 
patients with stage II DE was accompanied by the intensification 
of  the  ascending  activating  effects  of  the  nonspecific  brain 
structures on the cortex of the large hemispheres that were 
expressed by the predominance of rhythmical slow wave 
activity (“theta”) in the patients with MCI associated with DE. 
                        Figure 1.  
Distribution of the patients according to MCI type
                            Figure 2.
        Parameters of the neuropsychological tests in patients with CCI
Table 2. 
EEG findings in patients with CCI
Parameter Normal age-related 
memory loss 
(n=9)
MCI 
  (n=40)
P
Тhеtа-diapasone
PO lead 26.1±0.86 28.4±0.9 <0.001
PT lead 19.4±0.89 26.3±0.85 <0.01
Beta-diapasone
PO lead 52.9±0.3 57.4±0.6 <0.05
Alpha-rhythm
PO lead 10.3±0.2 8.7±0.75 <0.001
Coherence of alpha-diapasone
PO lead 0.64±0.11 0.5±0.8 <0.05
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A reduction in the coherence of alpha rhythmic activity in these 
patients indicated a disturbance in the links between the remote 
segments of the cortex as well as the intrahemispheric ones. This 
reduction in the optimization of the activity in the cortex resulted 
in damage of the cortical-subcortical links that were expressed 
in the integrated disorders in the brainwork. Clinically, this was 
expressed by the neuropsychological syndromes of the cortex 
of the frontal lobes. Besides, in the patients with stage II DE, 
we  found  agnosia  and  apraxia  that  reflect  the  predominantly 
cortical involvement of these disorders. Thus, the EEG changes 
revealed in the patients with DE were dependent upon the stage 
of cognitive defect and were specific in character. The results 
of the clinical investigations were confirmed in the analysis of 
parameters of CEP. Data are shown in Table 3.
During the study of CEP we analyzed P300 peak latency, 
P300 peak amplitude, the latency/amplitude ratio (R), N2 and 
N3 peak latencies, N3-P3 peak-to-peak amplitude. The analysis 
of the dynamics of the neurophysiological parameters by the 
data of CEP (P300) showed reliable differences when compared 
with the control group. This was expressed by the shortening of 
P300 peak latency and an increase in P300 peak amplitude as a 
consequence of this decrease in the latency/amplitude ratio (R).   
Based on a study of other CEP parameters, the changes were not 
statistically significant between parameters of the main group 
and the control group that indicated the insufficient information 
of these parameters for the diagnosis and prognosis of MCI 
associated with DE. The results of the investigations indicated a 
reduction in the metabolic processes in the brain cells caused by 
DE that manifested clinically as a reduction in both parameters of 
neuropsychological tests and the parameters of P300 peak. Based 
on the results obtained, the following conclusions were drawn:
	Discirculatory encephalopathy was accompanied by 
cognitive impairments of various degrees of severity. 
Normal age-related memory loss was observed in 14.9% 
while MCI was seen in 66.7% of the cases.
	Among the types of MCI, the disregulatory type was 
observed in 51.6% of patients with stage II-III DE, and 
the combined type was observed in 45.4% of patients 
with stage III DE.
	The EEG-pattern in patients with DE has some 
peculiarities that are expressed in the predominance of 
rhythmical slow wave activity and the reduction in the 
coherence of alpha rhythmic activity that results in a 
consequent disturbance of the integrated brain activity.
	 Changes in CEP data were expressed in the shortening 
of P300 peak latency  and an increase in P300 peak 
amplitude and consequently, a reduction the latency/
amplitude ratio in patients having MCI associated with 
DE.
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Table 3. 
Parameters of CEP (P300) in patients with CCI
Parameter Group I
(n=60)
Group II
(n=15)
P300 peak latency, m/sec. 374* 361
P300 peak amplitude, µW 5.2* 5.3
latency/amplitude ratio (R) 71.9* 68.1
N2 peak latency, ms 264.26 264.1
N3 peak latency, ms 461.28 459.8
N3-P3 peak-to-peak amplitude, µW 6.19 6.12
*P<0.05 between groups.